loading

Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten

pulisher
06:55 AM

How geopolitical risks impact Larimar Therapeutics Inc. (ZA71) stockWeekly Investment Report & Free Reliable Trade Execution Plans - newser.com

06:55 AM
pulisher
Nov 03, 2025

Why Larimar Therapeutics Inc. stock is favored by pension fundsWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Larimar Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What institutional flow reveals about Larimar Therapeutics Inc.July 2025 Catalysts & Smart Allocation Stock Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What machine learning models say about Larimar Therapeutics Inc.Earnings Trend Report & Capital Efficient Trade Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How moving averages guide Larimar Therapeutics Inc. tradingTrade Risk Summary & Community Trade Idea Sharing - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Larimar Therapeutics Inc. (ZA71) stock stays undervaluedSwing Trade & Community Verified Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Detecting price anomalies in Larimar Therapeutics Inc. with AIJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying chart zones and confluence areas to Larimar Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Larimar Therapeutics Inc. stock retracement – recovery analysisDay Trade & Free Community Consensus Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Larimar Therapeutics Inc. stock trades during market volatility2025 Volume Leaders & Reliable Entry Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Larimar Therapeutics Inc. (ZA71) stock behaves in tightening cycles2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Larimar Therapeutics Inc. (ZA71) stock positioned for digital growth era2025 Volume Leaders & High Conviction Investment Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 03, 2025
pulisher
Nov 02, 2025

Will Larimar Therapeutics Inc. stock benefit from automationEarnings Beat & AI Enhanced Trading Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Larimar Therapeutics Inc. (ZA71) stock worth buying before Fed actionWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Price action breakdown for Larimar Therapeutics Inc.Weekly Gains Summary & Safe Capital Allocation Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Custom watchlist performance reports with Larimar Therapeutics Inc.July 2025 Final Week & Low Drawdown Trading Strategies - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Larimar Therapeutics Inc. stock gain from lower inflationSwing Trade & Safe Entry Point Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

What makes Larimar Therapeutics Inc. stock attractive to growth fundsJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Pattern recognition hints at Larimar Therapeutics Inc. upsidePortfolio Update Report & Weekly Hot Stock Watchlists - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 00:49:57 - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Multi factor analysis applied to Larimar Therapeutics Inc.July 2025 Chart Watch & Safe Entry Point Identification - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What analysts say about Larimar Therapeutics Inc ZA71 stockDividend Aristocrats List & Superior Capital Growth - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Larimar Therapeutics, Inc. (LRMR) And Encourages Shareholders to Reach Out - ACCESS Newswire

Oct 31, 2025
pulisher
Oct 31, 2025

2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Larimar Therapeutics, Inc. (LRMR) And Encourages Shareholders to Reach Out | NDAQ:LRMR | Press Release - Stockhouse

Oct 31, 2025
$37.95
price up icon 1.71%
$29.15
price up icon 1.67%
$102.21
price up icon 0.62%
$103.58
price down icon 0.18%
biotechnology ONC
$315.16
price up icon 1.13%
$185.89
price down icon 0.42%
Kapitalisierung:     |  Volumen (24h):